Research Articles on Tuberculosis from 1940 onwards

Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacteriumtuberculosis energetics.
Future Microbiol. 2018 Sep;13:1383-1402.
Drug resistance mechanisms and drug susceptibility testing for tuberculosis.
Respirology. 2018 Dec;23(12):1098-1113.
Mechanistic investigation of resistance via drug-inactivating enzymes in Mycobacteriumtuberculosis.
Drug Metab Rev. 2018 Nov 18:1-18.
Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-ResistantMycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
https://www.ncbi.nlm.nih.gov/pubmed/29336677
Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy.
J Antibiot (Tokyo). 2018 Nov;71(11):939-949.
Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.
Bioorg Med Chem. 2018 Sep 15;26(17):4942-4951.
[Molecular Mechanisms of Drug Tolerance in Mycobacterium tuberculosis].
Mol Biol (Mosk). 2018 May-Jun;52(3):435-450.
Rethinking Drug Discovery and Targeting After the Genomic Revolution
https://www.researchgate.net/publication/326132669_Rethinking_Drug_Discovery_and_Targeting_After_the_Genomic_Revolution
Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosisthrough scaffold morphing from benzothiazinones.
Eur J Med Chem. 2018 Dec 5;160:157-170.
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.
J Bras Pneumol. 2018 Apr;44(2):153-160.